Logo image of PEN

PENUMBRA INC (PEN) Stock Fundamental Analysis

USA - NYSE:PEN - US70975L1070 - Common Stock

226.19 USD
-1.18 (-0.52%)
Last: 11/3/2025, 5:05:00 PM
227 USD
+0.81 (+0.36%)
After Hours: 11/3/2025, 5:05:00 PM
Fundamental Rating

6

Overall PEN gets a fundamental rating of 6 out of 10. We evaluated PEN against 189 industry peers in the Health Care Equipment & Supplies industry. PEN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PEN is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PEN suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

PEN had positive earnings in the past year.
PEN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PEN reported negative net income in multiple years.
In multiple years PEN reported negative operating cash flow during the last 5 years.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of PEN (8.82%) is better than 91.53% of its industry peers.
PEN's Return On Equity of 11.41% is amongst the best of the industry. PEN outperforms 88.36% of its industry peers.
With an excellent Return On Invested Capital value of 7.05%, PEN belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PEN is significantly below the industry average of 9.02%.
The 3 year average ROIC (2.98%) for PEN is below the current ROIC(7.05%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.82%
ROE 11.41%
ROIC 7.05%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

Looking at the Profit Margin, with a value of 11.54%, PEN belongs to the top of the industry, outperforming 86.24% of the companies in the same industry.
PEN's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 12.45%, PEN is doing good in the industry, outperforming 79.89% of the companies in the same industry.
In the last couple of years the Operating Margin of PEN has declined.
With a decent Gross Margin value of 66.47%, PEN is doing good in the industry, outperforming 70.90% of the companies in the same industry.
In the last couple of years the Gross Margin of PEN has remained more or less at the same level.
Industry RankSector Rank
OM 12.45%
PM (TTM) 11.54%
GM 66.47%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PEN is destroying value.
The number of shares outstanding for PEN has been reduced compared to 1 year ago.
PEN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PEN has an improved debt to assets ratio.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 15.82 indicates that PEN is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 15.82, PEN belongs to the best of the industry, outperforming 94.18% of the companies in the same industry.
The Debt to FCF ratio of PEN is 0.15, which is an excellent value as it means it would take PEN, only 0.15 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.15, PEN belongs to the top of the industry, outperforming 94.18% of the companies in the same industry.
PEN has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PEN (0.02) is better than 70.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Altman-Z 15.82
ROIC/WACC0.81
WACC8.73%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

PEN has a Current Ratio of 6.75. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN has a Current ratio of 6.75. This is amongst the best in the industry. PEN outperforms 84.13% of its industry peers.
PEN has a Quick Ratio of 4.04. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN has a Quick ratio of 4.04. This is in the better half of the industry: PEN outperforms 75.13% of its industry peers.
Industry RankSector Rank
Current Ratio 6.75
Quick Ratio 4.04
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

8

3. Growth

3.1 Past

PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.53%, which is quite impressive.
Measured over the past years, PEN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.23% on average per year.
PEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.92%.
PEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.89% yearly.
EPS 1Y (TTM)41.53%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%34.37%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%13.38%

3.2 Future

Based on estimates for the next years, PEN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.75% on average per year.
PEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.06% yearly.
EPS Next Y31.54%
EPS Next 2Y33.09%
EPS Next 3Y30.5%
EPS Next 5Y24.75%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.06%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 64.44, PEN can be considered very expensive at the moment.
PEN's Price/Earnings ratio is a bit cheaper when compared to the industry. PEN is cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of PEN to the average of the S&P500 Index (26.11), we can say PEN is valued expensively.
A Price/Forward Earnings ratio of 44.49 indicates a quite expensive valuation of PEN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 69.31% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of PEN to the average of the S&P500 Index (22.55), we can say PEN is valued expensively.
Industry RankSector Rank
PE 64.44
Fwd PE 44.49
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 66.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than the industry average as 74.07% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 54.58
EV/EBITDA 47.45
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PEN's earnings are expected to grow with 30.50% in the coming years.
PEG (NY)2.04
PEG (5Y)2.66
EPS Next 2Y33.09%
EPS Next 3Y30.5%

0

5. Dividend

5.1 Amount

PEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PENUMBRA INC

NYSE:PEN (11/3/2025, 5:05:00 PM)

After market: 227 +0.81 (+0.36%)

226.19

-1.18 (-0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners93.23%
Inst Owner Change-2.3%
Ins Owners3.71%
Ins Owner Change10.26%
Market Cap8.82B
Revenue(TTM)1.28B
Net Income(TTM)147.70M
Analysts82.5
Price Target320.45 (41.67%)
Short Float %4.62%
Short Ratio4.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.74%
Min EPS beat(2)3.63%
Max EPS beat(2)23.86%
EPS beat(4)4
Avg EPS beat(4)14.23%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)16.41%
EPS beat(12)12
Avg EPS beat(12)26.69%
EPS beat(16)13
Avg EPS beat(16)15.8%
Revenue beat(2)2
Avg Revenue beat(2)2.12%
Min Revenue beat(2)1.67%
Max Revenue beat(2)2.56%
Revenue beat(4)4
Avg Revenue beat(4)1.18%
Min Revenue beat(4)0.22%
Max Revenue beat(4)2.56%
Revenue beat(8)6
Avg Revenue beat(8)0.49%
Revenue beat(12)9
Avg Revenue beat(12)0.89%
Revenue beat(16)12
Avg Revenue beat(16)1.37%
PT rev (1m)0.5%
PT rev (3m)0.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.35%
EPS NY rev (1m)0.26%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.8%
Valuation
Industry RankSector Rank
PE 64.44
Fwd PE 44.49
P/S 6.89
P/FCF 54.58
P/OCF 43.78
P/B 6.82
P/tB 7.87
EV/EBITDA 47.45
EPS(TTM)3.51
EY1.55%
EPS(NY)5.08
Fwd EY2.25%
FCF(TTM)4.14
FCFY1.83%
OCF(TTM)5.17
OCFY2.28%
SpS32.82
BVpS33.18
TBVpS28.73
PEG (NY)2.04
PEG (5Y)2.66
Graham Number51.19
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 11.41%
ROCE 10.5%
ROIC 7.05%
ROICexc 9.79%
ROICexgc 11.64%
OM 12.45%
PM (TTM) 11.54%
GM 66.47%
FCFM 12.63%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score9
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Debt/EBITDA 0.12
Cap/Depr 209.19%
Cap/Sales 3.11%
Interest Coverage 250
Cash Conversion 112.96%
Profit Quality 109.42%
Current Ratio 6.75
Quick Ratio 4.04
Altman-Z 15.82
F-Score9
WACC8.73%
ROIC/WACC0.81
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.53%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%34.37%
EPS Next Y31.54%
EPS Next 2Y33.09%
EPS Next 3Y30.5%
EPS Next 5Y24.75%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%13.38%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.06%
EBIT growth 1Y48.52%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year74.3%
EBIT Next 3Y39.57%
EBIT Next 5Y26.5%
FCF growth 1Y31590.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y979.8%
OCF growth 3Y160.78%
OCF growth 5Y44.6%

PENUMBRA INC / PEN FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to PEN.


Can you provide the valuation status for PENUMBRA INC?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


What is the profitability of PEN stock?

PENUMBRA INC (PEN) has a profitability rating of 6 / 10.


What are the PE and PB ratios of PENUMBRA INC (PEN) stock?

The Price/Earnings (PE) ratio for PENUMBRA INC (PEN) is 64.44 and the Price/Book (PB) ratio is 6.82.


Can you provide the financial health for PEN stock?

The financial health rating of PENUMBRA INC (PEN) is 8 / 10.